SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1993 Registration number 2-56218 	A. Full title of the plan: ORAL-B LABORATORIES SAVINGS PLAN One Lagoon Drive Redwood City, CA 94065 	B. Name of the issuer of the securities held pursuant to the plan and the address of its principal executive office: The Gillette Company Prudential Tower Building Boston, MA 02199 Financial Statements of the Oral-B Laboratories Savings Plan 	In lieu of the requirements of Items 1 through 3, the Oral-B Laboratories Savings Plan is filing financial statements and schedules prepared in accordance with ERISA. Pursuant to Rule 311 of Regulation S-T, the financial statements and schedules are being filed in paper format under cover of Form SE and the following legend will appear on the transmittal letter accompanying the paper format documents: THIS PAPER FORMAT DOCUMENT IS BEING SUBMITTED IN ACCORDANCE WITH RULE 311 OF REGULATION S-T. Exhibits 	24	Consent of KPMG Peat Marwick to the 	 		incorporation by reference of the Plan's 		financial statements into Registration 	 		Statement No. 2-93230 on Form S-8 under 		the Securities Act of 1933. SIGNATURES 	Pursuant to the requirements of the Securities Exchange Act of 1934, the Savings Plan Committee has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized. Oral-B Laboratories Savings Plan By ROBERT E. DICENSO Robert E. DiCenso Senior Vice President-Administration The Gillette Company Date:	June 27, 1994